Compass therapeutics to participate in the stifel 2025 virtual targeted oncology forum

Boston, april 02, 2025 (globe newswire) -- compass therapeutics, inc. (nasdaq: cmpx), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the company will present at the stifel 2025 virtual targeted oncology forum taking place april 8-9, 2025.

CMPX Ratings Summary

CMPX Quant Ranking